Title: Young-Ming Huang: Innovator in Pharmaceutical Research
Introduction
Young-Ming Huang is an inventor based in I Lan, Taiwan. He is currently associated with Sinphar Tian-li Pharmaceutical Co., Ltd. Despite having no granted patents to his name, he is actively involved in innovative research aimed at addressing significant health challenges.
Latest Patent Applications
Young-Ming Huang has submitted several notable patent applications. One of his latest applications is titled "Pharmaceutical Composition for Preventing or Treating Amyloid Beta Peptide-Associated Diseases or Conditions." This application describes a pharmaceutical composition containing isoacteoside to the acteoside, which is capable of inhibiting the formation, accumulation, or aggregation of amyloid β peptides. This composition is particularly useful in preventing or treating diseases associated with amyloid beta peptides, with a specified weight ratio of isoacteoside to acteoside ranging from 4:1 to 1:4. Another significant application is "Method for Preventing or Treating Amyloid Beta Peptide-Associated Diseases or Conditions, and Method for Inhibiting Formation, Accumulation or Aggregation of Amyloid Beta Peptides." This application outlines the use of isoacteoside or a pharmaceutically acceptable salt thereof as an agent to prevent or treat amyloid beta peptide-associated diseases.
Conclusion
Young-Ming Huang is a dedicated inventor whose work focuses on innovative pharmaceutical solutions for amyloid beta peptide-related conditions. His ongoing research and patent applications reflect his commitment to advancing medical science and improving patient outcomes.